Status:
UNKNOWN
The Verona Newly Diagnosed Type 2 Diabetes Study
Lead Sponsor:
Universita di Verona
Collaborating Sponsors:
European Foundation for the Study of Diabetes
Ministry of Education, Universities and Research, Italy
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Brief Summary
Type 2 diabetes mellitus is a complex disease whose clinical phenotype results from the variable combination of genetic and nongenetic factors. The aim of the present study is to investigate the netwo...
Detailed Description
The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) is an ongoing study aiming at building a biobank of patients with newly diagnosed type 2 diabetes mellitus. All patients referred to the Divisio...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus, whose diagnosis has been made in the last six months before the first access to the Division of Endocrinology and Metabolic Diseases of University of Verona School of Medicine;
- Relatives of patients with potentially monogenic newly diagnosed type 2 diabetes
Exclusion
- Age \> 75 years
- Non-Italian ancestry
- Insulin treatment
- Presence of anti-GAD antibodies
- Malignancies
- Any condition severely impairing liver and/or kidney function
Key Trial Info
Start Date :
October 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT01526720
Start Date
October 1 2003
End Date
December 1 2020
Last Update
February 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Endocrinology and Metabolic Diseases - University Hospital of Verona
Verona, Italy, 37126